Literature DB >> 12368479

Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses.

Erika Geimonen1, Sherry Neff, Tracy Raymond, Salih S Kocer, Irina N Gavrilovskaya, Erich R Mackow.   

Abstract

Hantaviruses cause two human diseases: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). Hantaviruses infect human endothelial cells but cause little or no damage to the infected endothelium. We analyzed with Affymetrix DNA Arrays (Santa Clara, CA) the endothelial cell transcriptional responses directed by hantaviruses associated with HPS [New York-1 virus (NY-1V)], HFRS [Hantaan virus (HTNV)], or by a hantavirus not associated with human disease [Prospect Hill virus (PHV)]. Hantavirus infections induced 117 cellular genes and repressed 25 genes by >3-fold, 4 days postinfection (p.i.). Although >80% of cells were infected by each virus 1 day p.i., PHV induced or repressed 67 genes at this early time compared with three genes altered by HTNV or NY-1V. The early high-level induction of 24 IFN-stimulated genes by PHV (4- to 229-fold) represents a fundamental difference in the temporal regulation of cellular responses by pathogenic and nonpathogenic hantaviruses. Because all hantaviruses induced >23 IFN-stimulated genes at late times p.i., pathogenic hantaviruses appear to suppress early cellular IFN responses that are activated by nonpathogenic hantaviruses. At late times p.i., 13 genes were commonly induced by HTNV and NY-1V that were not induced by PHV. In contrast to NY-1V, HTNV uniquely induced a variety of chemokines and cell adhesion molecules (i.e., IL-8, IL-6, GRO-beta, ICAM), as well as two complement cascade-associated factors that may contribute to immune components of HFRS disease. NY-1V failed to induce most cellular chemokines directed by HTNV (3/14) or genes primarily activated by NF-kappaB. However, NY-1V uniquely induced beta3 integrin-linked potassium channels, which could play a role in HPS-associated vascular permeability. These studies provide a basic understanding of hantavirus-directed cellular responses that are likely to differentiate pathogenic and nonpathogenic hantaviruses, contribute to HFRS and HPS pathogenesis, and provide insight into disease mechanisms and potential therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368479      PMCID: PMC129784          DOI: 10.1073/pnas.192298899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Chemokines and chemokine receptors in infectious diseases.

Authors:  S Mahalingam; G Karupiah
Journal:  Immunol Cell Biol       Date:  1999-12       Impact factor: 5.126

Review 2.  Human immune response, host genetics, and severity of disease.

Authors:  O Vapalahti; A Lundkvist; A Vaheri
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

3.  A mechanism for modulation of cellular responses to VEGF: activation of the integrins.

Authors:  T V Byzova; C K Goldman; N Pampori; K A Thomas; A Bett; S J Shattil; E F Plow
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

4.  The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models.

Authors:  A D Medhurst; D C Harrison; S J Read; C A Campbell; M J Robbins; M N Pangalos
Journal:  J Neurosci Methods       Date:  2000-05-15       Impact factor: 2.390

5.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions.

Authors:  R E Gerszten; E A Garcia-Zepeda; Y C Lim; M Yoshida; H A Ding; M A Gimbrone; A D Luster; F W Luscinskas; A Rosenzweig
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

6.  Complement activation in nephropathia epidemica caused by Puumala hantavirus.

Authors:  A Paakkala; J Mustonen; M Viander; H Huhtala; A Pasternack
Journal:  Clin Nephrol       Date:  2000-06       Impact factor: 0.975

Review 7.  Potassium channel function in vascular disease.

Authors:  C G Sobey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

8.  Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets.

Authors:  H M Verheul; A S Jorna; K Hoekman; H J Broxterman; M F Gebbink; H M Pinedo
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

Review 9.  Cellular receptors and hantavirus pathogenesis.

Authors:  E R Mackow; I N Gavrilovskaya
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

Review 10.  The splice variants of vascular endothelial growth factor (VEGF) and their receptors.

Authors:  C J Robinson; S E Stringer
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  85 in total

1.  Genetic reassortment between high-virulent and low-virulent Dobrava-Belgrade virus strains.

Authors:  Sina Kirsanovs; Boris Klempa; Renate Franke; Min-Hi Lee; Günther Schönrich; Andreas Rang; Detlev H Kruger
Journal:  Virus Genes       Date:  2010-08-24       Impact factor: 2.332

2.  Elevated sICAM-1 levels in patients with hemorrhagic fever with renal syndrome caused by Hantaan virus.

Authors:  Qunying Han; Lei Zhang; Zhengwen Liu; Wen Kang; Sai Lou; Jianming Qiu; Zhu Li; Guoyu Zhang; Yawen Wang; Man Li; Na Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-21       Impact factor: 3.267

3.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

4.  Seoul virus suppresses NF-kappaB-mediated inflammatory responses of antigen presenting cells from Norway rats.

Authors:  Rebecca Y Au; Anne E Jedlicka; Wei Li; Andrew Pekosz; Sabra L Klein
Journal:  Virology       Date:  2010-02-18       Impact factor: 3.616

5.  The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses.

Authors:  Peter J Alff; Irina N Gavrilovskaya; Elena Gorbunova; Karen Endriss; Yuson Chong; Erika Geimonen; Nandini Sen; Nancy C Reich; Erich R Mackow
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques.

Authors:  David Safronetz; Joseph Prescott; Friederike Feldmann; Elaine Haddock; Rebecca Rosenke; Atsushi Okumura; Douglas Brining; Eric Dahlstrom; Stephen F Porcella; Hideki Ebihara; Dana P Scott; Brian Hjelle; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

7.  Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail.

Authors:  Erika Geimonen; Imelyn Fernandez; Irina N Gavrilovskaya; Erich R Mackow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Differential pathogenesis between Andes virus strains CHI-7913 and Chile-9717869in Syrian Hamsters.

Authors:  Bryce M Warner; Angela Sloan; Yvon Deschambault; Sebastian Dowhanik; Kevin Tierney; Jonathan Audet; Guodong Liu; Derek R Stein; Oliver Lung; Cody Buchanan; Patrycja Sroga; Bryan D Griffin; Vinayakumar Siragam; Kathy L Frost; Stephanie Booth; Logan Banadyga; Greg Saturday; Dana Scott; Darwyn Kobasa; David Safronetz
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

9.  Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin.

Authors:  Li-Wu Qian; Whitney Greene; Fengchun Ye; Shou-Jiang Gao
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Hantaviruses induce antiviral and pro-inflammatory innate immune responses in astrocytic cells and the brain.

Authors:  Ok Sarah Shin; Gabriella Shinyoung Song; Mukesh Kumar; Richard Yanagihara; Ho-Wang Lee; Jin-Won Song
Journal:  Viral Immunol       Date:  2014-06-17       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.